Today at #AACR26, Mohammad Mousaei Ghasroldasht, PhD, presents on how Nectin-4 targeted CAR-engineered NK cells are improving tumor recognition in bladder cancer. Stop by his poster to learn more about these advances.
@uchicagosurgery